Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab-Reference-Cited by-同舟云学术

Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab

Published:2019-07-12 Issue:3 Volume:19 Page:267-275
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Köhne Claus-Henning,Karthaus Meinolf,Mineur Laurent,Thaler Josef,Van den Eynde Marc,Gallego Javier^ORCID,Koukakis Reija,Berkhout Marloes,Hofheinz Ralf-Dieter

Funder

Amgen (Europe) GmbH

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40268-019-0278-8.pdf

Reference31 articles.

1. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386–422.

2. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: colon cancer. Version 2. 2019. https://www.nccn.org/professionals/physician_gls/pdf/colon_blocks.pdf. Accessed 13 June 2019.

3. Kohne CH, Hofheinz R, Mineur L, Letocha H, Greil R, Thaler J, et al. First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer. J Cancer Res Clin Oncol. 2012;138:65–72.

4. Karthaus M, Hofheinz R-D, Mineur L, Letocha H, Greil R, Thaler J, et al. Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer. Br J Cancer. 2016;115:1215–22.

5. European Medicines Agency. Vectibix® (panitumumab): summary of product characteristics. 2018. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000741/WC500047710.pdf. Accessed 13 June 2019.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of monoclonal antibodies for colorectal cancer therapy;Medical Oncology;2023-08-21

2. Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition;Journal of Gastrointestinal Oncology;2022-12

3. Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer;Clinical Colorectal Cancer;2021-12

4. Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109);Journal of Cancer Research and Clinical Oncology;2020-05-24